Expand KPTI Menu
KPTI MENU

KPTI Latest Press Releases

-- February 17, 2026 --

Registration Momentum Builds Across the Oncology Pipeline Globe Newswire 10:48 AM

-- February 12, 2026 --

Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress PRNewswire 7:30 AM

-- February 5, 2026 --

Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 PRNewswire 7:30 AM

-- February 2, 2026 --

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PRNewswire 4:05 PM

-- January 12, 2026 --

Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026 PRNewswire 7:00 AM

-- January 2, 2026 --

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PRNewswire 4:05 PM

-- December 8, 2025 --

Karyopharm to Participate in Baird's Biotech Discovery Series PRNewswire 7:00 AM

-- December 1, 2025 --

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PRNewswire 4:05 PM
Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference PRNewswire 7:00 AM

-- November 3, 2025 --

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PRNewswire 4:08 PM
Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress PRNewswire 7:00 AM

-- October 27, 2025 --

Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025 PRNewswire 7:00 AM

-- October 8, 2025 --

Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis PRNewswire 7:01 AM

-- October 1, 2025 --

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PRNewswire 4:08 PM
Market Data Delayed 15 Minutes